Status:
RECRUITING
Use of CGM in Kidney Transplant Recipients
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Kidney Transplant; Complications
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant popu...
Detailed Description
Diabetes is one of the leading causes of End Stage Renal Disease (ESRD). Kidney transplantation is the best form of renal replacement therapy to date but requires that recipients of transplant organs ...
Eligibility Criteria
Inclusion
- Age 18 or above
- Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
- Person with Type 2 Diabetes and on insulin
- Access to home wi-fi connection
Exclusion
- Person with Type 1 Diabetes
- Patients taking hydroxyurea
- Patient unable to wear the Dexcom G6 device at all times for any reason
- Must be able to test blood glucose with meter 4x a day when on blinded CGM.
- Presence of clinically significant visual or cognitive impairment
- Illiterate
- Prisoners
- Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
- Presence of clinically unstable cardiovascular disease
- Active malignancy treatment
Key Trial Info
Start Date :
June 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04783441
Start Date
June 29 2021
End Date
December 31 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Health
Sacramento, California, United States, 95817